FDA Inspection 1242063 — Hunan Jiudian Hongyang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hunan Jiudian Hongyang Pharmaceutical Co., Ltd. on May 17, 2024 in Changsha. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changsha (China)